This is a working overview of Anomer, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-29 and is reviewed periodically as new material appears.
Identity and purity are usually assessed with complementary methods. Nuclear magnetic resonance spectroscopy can confirm the molecular structure and distinguish anomeric forms. High-performance liquid chromatography with ultraviolet detection or mass spectrometry is common for assay and related-substance testing. Mass spectrometry also supports trace quantification in biological samples, often with isotope-labeled internal standards. Because NMN lacks a strong chromophore, some ultraviolet methods require careful wavelength selection or derivatization, and laboratories may validate each approach for its intended matrix.
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | −20 °C or below | Dry, desiccated, protected from light |
| Aqueous solubility | High | Stability is pH- and temperature-dependent |
| Identity method | NMR spectroscopy | Confirms structure and anomeric form |
| Purity method | HPLC-UV or LC-MS | Measures assay and related substances |
| Common salt forms | Free acid; sodium salt | Counterion changes mass and hygroscopicity |
Regulatory treatment of NMN differs by country and has changed over time. In the United States, the Food and Drug Administration has stated that NMN is excluded from the definition of a dietary supplement because it was investigated as a drug before being marketed as a supplement; enforcement and legal interpretation continue to evolve. In the European Union, NMN may require authorization as a novel food before sale. In Japan, NMN has been marketed in some food products, while it is not approved as a therapeutic drug in major markets. These categories affect labeling, permitted claims, and quality oversight.
Solid NMN is generally handled as a moisture-sensitive and light-sensitive material. Suppliers commonly recommend storage at minus 20 degrees Celsius in a sealed, desiccated container, protected from light. Aqueous solutions are less stable than the solid and may degrade faster at elevated temperatures or extreme pH values. Because NMN contains a phosphate ester and a glycosidic bond, hydrolysis and other degradation pathways are plausible under unfavorable conditions. Stability data from independent laboratories remain limited, so handling recommendations often reflect supplier practice rather than published consensus.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Quality control for NMN materials typically includes identity, assay, purity, and impurity profiling. Tests may cover residual solvents, heavy metals, microbial limits, and water content, depending on the intended use and local rules. Impurity profiles can include related substances such as nicotinamide, nicotinamide riboside, and NAD+, which may form during synthesis or storage. Because commercial NMN can be offered as different salts or hydrate forms, a certificate of analysis should state the form and the analytical methods used. Independent verification is relevant because supplement markets vary in testing requirements and enforcement.
Laboratory identification of NMN usually relies on chromatographic separation coupled with ultraviolet or mass spectrometric detection. High-performance liquid chromatography with UV absorbance can quantify the compound against a reference standard, while liquid chromatography-tandem mass spectrometry offers lower detection limits and better specificity in complex matrices. Nuclear magnetic resonance spectroscopy can confirm structural identity and isomeric form. Ion chromatography or capillary electrophoresis may be used to identify counterions such as sodium. Method validation includes accuracy, precision, linearity, and limits of detection.
== Family == The only child of Thorburn Robertson (1851–1932), and Sarah Ann Robertson (1859-?), née Brailsford, Thorburn Brailsford Robertson was born at Edinburgh, Scotland on 4 March 1884. In the early 1890s he migrated to South Australia with his mother to join his father who was attorney for Kangarilla Silver Mines Ltd, and the manager of its copper mine at Callington, near Murray Bridge, South Australia. The Robertsons lived at Callington for a number of years.
=== EC 1.3.3 With oxygen as acceptor === EC 1.3.3.1: dihydroorotate oxidase EC 1.3.3.2: Now EC 1.14.19.20 Δ7-sterol 5(6)-desaturase EC 1.3.3.3: coproporphyrinogen oxidase EC 1.3.3.4: protoporphyrinogen oxidase EC 1.3.3.5: bilirubin oxidase EC 1.3.3.6: acyl-CoA oxidase EC 1.3.3.7: dihydrouracil oxidase EC 1.3.3.8: tetrahydroberberine oxidase EC 1.3.3.9: Now EC 1.14.19.62 secologanin synthase EC 1.3.3.10: tryptophan a,b-oxidase EC 1.3.3.11: pyrroloquinoline-quinone synthase EC 1.3.3.12: l-galactonolactone oxidase
=== Medication === Medication is used in a similar way as for other chronic pain conditions, and can be used as a treatment for related joint pain. Nonsteroidal anti-inflammatory drugs and acetaminophen are used to treat pain. Opioids are often used, and prescribed for many with hypermobile Ehlers-Danlos syndrome.
Substrates produce metabolic fatigue by being depleted during exercise, resulting in a lack of intracellular energy sources to fuel contractions. In essence, the muscle stops contracting because it lacks the energy to do so.
==== Martyrs ==== The decision as to whether martyrs had died for their faith in Christ and the consequent permission of veneration lay originally with the bishop of the place in which they had borne their testimony. The bishop inquired into the motive of the person's death and, on finding they had died a martyr, sent their name with an account of their martyrdom to other churches, especially neighboring ones, so that, in the event of approval by their respective bishops, the cultus of the martyr might extend to their churches also and that the faithful, as is said of Ignatius of Antioch in the "Acts" of his martyrdom "might hold communion with the generous martyr of Christ" (generoso Christi martyri communicarent). Martyrs whose cause, so to speak, had been discussed, and the fame of whose martyrdom had been confirmed, were known as proved (vindicati) martyrs. That word probably did not antedate the fourth century, when it was introduced into the Church at Carthage; but the fact is certainly older. In the earlier ages, therefore, this veneration was entirely local and passed from one church to another with the permission of their bishops. This is clear from the fact that in ancient Christian cemeteries there are found paintings of only those martyrs who had suffered in that neighborhood. It explains, also, the almost universal veneration very quickly paid to, e.g., Lawrence, Cyprian, and Sixtus II, who were killed by the Roman Emperor Valerian.
Sources: en.wikipedia.org
=== Models === A variety of theoretical frameworks exist to model optical, electronic, and structural properties of quantum dots. These may be broadly divided into quantum mechanical, semiclassical, and classical.
Triple-stranded DNA structures were common hypotheses in the 1950s when scientists were struggling to discover DNA's true structural form. Watson and Crick (who later won the Nobel Prize for their double-helix model) originally considered a triple-helix model, as did Pauling and Corey, who published a proposal for their triple-helix model in 1953, as well as fellow scientist Fraser. However, Watson and Crick soon identified several problems with these models:
== Spectrum of activity == Tylosin has a wide spectrum of activity against Gram-positive bacteria including Staphylococcus, Streptococcus, Corynebacterium, and Erysipelothrix. It has a much narrower Gram-negative spectrum of activity, but has been shown to be active against Campylobacter coli, and certain spirochaetes. It has also been shown to be extremely active against Mycoplasma species isolated from both mammalian and avian hosts. The following represents MIC susceptibility data for a few medically significant pathogens:
The side corridors are structurally highly sophisticated and remain visible to this day. A low platform runs along the external wall of each corridor, on which rows of statues were displayed, with murals behind them including the figure of the painter in tunic and boots. Above them, the top of each corridor formed a high vault, equipped with a lunette on the southern side, and decorated over its length with rows of devatas behind a balustrade, standing around a Buddha Maitreya, and on top of them landscapes with rhombus losange designs with monks, animals, trees and ponds, of the type seen in vault of the Cave of the Hippocampi (Cave 118).
α (orthorhombic) stable up to 668 °C (1,234 °F). Orthorhombic, space group No. 63, Cmcm, lattice parameters a = 285.4 pm, b = 587 pm, c = 495.5 pm. β (tetragonal) stable from 668 to 775 °C (1,234 to 1,427 °F). Tetragonal, space group P42/mnm, P42nm, or P4n2, lattice parameters a = 565.6 pm, b = c = 1075.9 pm. γ (body-centered cubic) from 775 °C (1,427 °F) to melting point—this is the most malleable and ductile state. Body-centered cubic, lattice parameter a = 352.4 pm.
Sources: en.wikipedia.org
=== Making films 1941–1948 === From September 1941 Thomas worked for the Strand Film Company in London. Strand produced films for the Ministry of Information and Thomas produced film scripts for six such films in 1942: This is Colour (on aniline dye processing), New Towns for Old, Balloon Site 568 (a recruitment film), CEMA (on arts organisation), Young Farmers and Battle for Freedom. He also scripted and produced Wales – Green Mountain, Black Mountain, a British Council commission and a bi-lingual production. These Are The Men (1943) was a more ambitious piece in which Thomas's verse accompanies Leni Riefenstahl's footage of an early Nuremberg Rally. Conquest of a Germ (1944) explored the use of early antibiotics in the fight against pneumonia and tuberculosis. Our Country (1945) was a romantic tour of Britain set to Thomas's poetry. Thomas continued to work in the film industry after the war, working on feature film scripts which included: No Room at the Inn (1948), The Three Weird Sisters (1948), The Doctor and the Devils (1944—not produced until 1985) and Rebecca's Daughters (1948—not produced until 1992). His screenplay for The Beach of Falesá, not produced as a film, received a BBC Radio 3 production in May 2014. Altogether in his work in the film industry Thomas produced 28 film scripts (not all of which reached production) as well as acting as producer and director in some cases. When recession overtook the film industry in the late 1940s he lost his most reliable source of income.
Carrillo-Briceño et al. (2026) report evidence of exploitation of glyptodonts, ground sloth, proboscideans, macraucheniids and toxodontids by Pleistocene humans from the Taima-Taima site (Venezuela). Eren et al. (2026) provide estimates for the first appearance of the atlatl in western North America on the basis of analysis of the archaeological record, and find no evidence supporting atlatl use by foragers from the Clovis culture. Pettigrew et al. (2026) report evidence from naturalistic experiments indicating that the atlatl was able to deliver fatal wounds to megafauna, including animals as large as mammoths. He et al. (2026) reconstruct the course of peopling of East Asia and subsequent diversification of populations from the studied area during the Paleolithic and Neolithic on the basis of data from Y chromosome genomic data from ancient and modern individuals. Zhang et al. (2026) sequence genomes of individuals from the Donghulin site in the North China Plain, and report evidence of population changes over two millennia during the Paleolithic-Neolithic transition. A partial humerus with morphological affinities with Late Upper Paleolithic modern humans is described from early Holocene strata from Heilongjiang (China) by Wei et al. (2026). Bourgon et al. (2026) report evidence from zinc stable isotope analysis of tooth enamel of humans from the late Pleistocene and Holocene sites from Sri Lanka indicative of a mixed diet including both animal and plant foods, with the plant component of the diet increasing over time (even before the introduction of crop agriculture).
Disuse atrophy of muscles and bones, with loss of mass and strength, can occur after prolonged immobility, such as extended bedrest, or having a body part in a cast (living in darkness for the eye, bedridden for the legs etc.). This type of atrophy can usually be reversed with exercise unless severe. There are many diseases and conditions which cause atrophy of muscle mass. For example, diseases such as cancer and AIDS induce a body wasting syndrome called cachexia, which is notable for the severe muscle atrophy seen. Other syndromes or conditions which can induce skeletal muscle atrophy are congestive heart failure and liver disease. During aging, there is a gradual decrease in the ability to maintain skeletal muscle function and mass. This condition is called sarcopenia, and may be distinct from atrophy in its pathophysiology. While the exact cause of sarcopenia is unknown, it may be induced by a combination of a gradual failure in the satellite cells which help to regenerate skeletal muscle fibers, and a decrease in sensitivity to or the availability of critical secreted growth factors which are necessary to maintain muscle mass and satellite cell survival.
== History and taxonomy == Aspergillus parasiticus was first discovered in 1912 by pathopathologist, A.T Speare from dead mealy bugs collected on Hawaiian sugarcane plantations. The species epithet, "parasiticus" is derived from the Latin word meaning "parasite" and was selected due to the ability of the fungus to parasitize other organisms. The fungus was originally classified as a subspecies of A. flavus called Aspergillus flavus subsp. parasiticus (Speare) due to its strong resemblance to A. flavus. Indeed, this fungus is very closely related to A. flavus and is often misidentified as the latter. However, the two species are separable based on morphological features. A. parasiticus also exhibits physiological differences from A. flavus such as the inability to produce cyclopiazonic acid and the production of aflatoxin G.
Sources: en.wikipedia.org
Purity is commonly measured by high-performance liquid chromatography with ultraviolet or mass spectrometric detection. Nuclear magnetic resonance can confirm identity and anomeric composition. Water content and residual solvents may be tested separately.
Dry NMN is typically stored refrigerated or frozen in a desiccated container. Solutions are less stable and should be kept cold and used promptly. Protection from light and moisture helps limit degradation.
Beta-NMN is the naturally occurring anomer involved in NAD+ production. Alpha-NMN can form during synthesis and is often tracked as an impurity. Analytical methods such as NMR or HPLC can distinguish the two forms.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in the cellular production of NAD+.